By Ana Mano SAO PAULO (Reuters) -Brazilian meatpacker JBS SA defended the structure of a proposed dual listing that will go to shareholders for approval this month, saying on Wednesday that the plan is an attractive value proposition to investors in the long term. If approved by minority shareholders on May 23, the plan – …
Brazil’s JBS defends dual listing proposal following criticism, shares fall Read More »
(Reuters) – U.S. rare earths miner MP Materials said on Wednesday it has signed a memorandum of understanding with Saudi Arabia’s flagship mining company Maaden to jointly develop a rare earth supply chain in the Middle Eastern country. WHY IT’S IMPORTANT The agreement was signed on the sidelines of the U.S.-Saudi Investment Forum, where President …
MP Materials, Maaden to jointly develop rare earths supply chain in Saudi Read More »
(Reuters) -Uber Technologies on Wednesday unveiled a range of new offerings such as shared fixed-route rides and expanded membership passes, targeting consumers seeking cost-effective ways to travel. The ride-sharing app has been looking to invest in more affordable transport and delivery offerings to widen its user base and combat slowing revenue growth in an uncertain …
Uber bets on affordability with shared fixed-route rides, expanded passes Read More »
By Michael S. Derby and Marc Jones NEW YORK (Reuters) -Central banks should still be able to conduct monetary policy effectively and perhaps be even nimbler in a more decentralized financial system, according to the findings of a joint report released on Wednesday by the New York Federal Reserve and the Bank for International Settlements. …
Central bank project shows monetary policy still viable in ‘tokenized’ system Read More »
By Maggie Fick LONDON (Reuters) -Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry grows that layoffs and policy changes at the drugs watchdog under the Trump administration may delay regulatory reviews, executives, investors, and consultants told Reuters. The U.S. Food and Drug Administration is seen …
FDA upheaval pushes some biotech firms to plan early trials out of US Read More »
By Roshan Thomas and Rishav Chatterjee (Reuters) – Australia’s Insignia Financial said on Wednesday that Bain Capital has pulled its buyout offer due to volatile financial markets, but the money manager added it was still in talks with another suitor, investment manager CC Capital. Private equity firm Bain’s proposal valued Insignia at A$3.34 billion ($2.2 …
(Reuters) – Advanced Micro Devices on Wednesday announced a new $6 billion stock buyback plan, joining a string of chipmakers that are looking to reduce their float as the AI trade that has powered their shares shows some signs of slowing. Shares of the Santa Clara, California-based company rose as much as 6.4%. Its shares …
AI chipmaker AMD unveils $6 billion buyback plan Read More »
(Reuters) – Carlyle Group and SK Capital Partners increased their upfront offer to take over gene therapy maker bluebird bio, the companies said on Wednesday. Shares of bluebird bio jumped over 50% to $4.97 in early trading. The private equity firms made a new offer of $5 per share upfront, while the previous bid had …
Bluebird bio receives higher upfront offer from PE firms Carlyle, SK Capital Read More »
CHICAGO (Reuters) – U.S. cattle producers have started rebuilding the nation’s herd or are close to doing so, Tyson Foods CEO Donnie King said on Wednesday, after supplies dwindled to a 74-year low. Tight cattle inventories have driven up beef prices for U.S. consumers and forced meatpackers, including Tyson and rivals like Cargill and JBS, …
US cattle producers have started rebuilding herds, or will soon, Tyson Foods CEO says Read More »
By Howard Schneider (Reuters) -Recent inflation data point to continued progress toward meeting the U.S. Federal Reserve’s 2% inflation goal, but the outlook is now uncertain due to the possibility new import taxes will drive prices higher, Fed Vice Chair Philip Jefferson said on Wednesday. Consumer prices in April rose less than analysts expected, but …
Fed’s Jefferson: Expect economy to slow, future inflation uncertain due to tariffs Read More »
